National Peroxide Ltd is Rated Sell

Feb 17 2026 10:10 AM IST
share
Share Via
National Peroxide Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.
National Peroxide Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s 'Sell' rating for National Peroxide Ltd indicates a cautious stance towards the stock, suggesting that investors should consider reducing exposure or avoiding new purchases at this time. This rating reflects a comprehensive evaluation of the company’s quality, valuation, financial trend, and technical indicators. While the rating was revised from 'Strong Sell' to 'Sell' on 06 February 2026, the current assessment as of 17 February 2026 shows some improvement, though risks remain significant.

Quality Assessment

As of 17 February 2026, National Peroxide Ltd holds an average quality grade. This suggests that while the company maintains some operational stability, it lacks the robust growth and profitability characteristics that investors typically seek in higher-rated stocks. The company’s long-term growth has been disappointing, with net sales declining at an annualised rate of -12.60% over the past five years. Operating profit has deteriorated even more sharply, shrinking by -135.58% annually during the same period. These figures highlight persistent challenges in generating sustainable earnings growth.

Valuation Perspective

The valuation grade for National Peroxide Ltd is classified as risky. The stock currently trades at levels that do not adequately compensate investors for the underlying business risks. Negative operating profits and a lack of positive earnings momentum contribute to this assessment. Over the past year, the stock has delivered a return of -32.65%, underperforming broader market indices such as the BSE500. This weak performance, combined with stretched valuations relative to historical averages, signals caution for prospective investors.

Financial Trend Analysis

Despite the negative growth trends, the financial grade is marked as positive, reflecting some stabilisation or improvement in recent financial metrics. However, this positive grading should be interpreted in context: the company’s operating profits remain negative, and the overall financial health is fragile. The latest data as of 17 February 2026 shows that while there may be some short-term financial improvements, the longer-term trajectory remains concerning. The stock’s returns over the last six months and three months have been -30.49% and -26.72% respectively, underscoring ongoing challenges.

Technical Outlook

From a technical standpoint, National Peroxide Ltd is rated bearish. The stock’s price action reflects downward momentum, with recent declines and weak relative strength compared to sector peers and broader indices. The one-day gain of 1.07% on 17 February 2026 offers only a minor respite amid a generally negative trend. Technical indicators suggest limited near-term upside, reinforcing the cautious 'Sell' rating.

Stock Returns and Market Performance

As of 17 February 2026, National Peroxide Ltd’s stock has experienced significant declines across multiple time frames. The one-year return stands at -32.65%, while the year-to-date performance is down by -9.19%. Shorter-term returns also reflect weakness, with the stock falling -2.48% over the past month and -2.37% over the last week. These figures highlight the stock’s underperformance relative to the broader market and its sector, signalling persistent investor concerns.

Long-Term Growth Challenges

The company’s long-term growth profile remains a key concern. Negative annualised growth rates in net sales and operating profit over five years indicate structural issues in business operations or market positioning. This poor growth record weighs heavily on investor sentiment and valuation metrics, limiting the stock’s appeal despite any short-term financial improvements.

From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!

  • - Early turnaround signals
  • - Explosive growth potential
  • - Textile - Machinery recovery play

Position for Explosive Growth →

Investor Implications

For investors, the 'Sell' rating on National Peroxide Ltd suggests prudence. The combination of average quality, risky valuation, a fragile financial trend, and bearish technicals indicates that the stock is not currently positioned for strong performance. Investors should carefully consider their risk tolerance and portfolio objectives before maintaining or initiating positions in this microcap commodity chemicals company.

Sector and Market Context

Operating within the commodity chemicals sector, National Peroxide Ltd faces competitive pressures and cyclical challenges that have contributed to its subdued performance. Compared to broader market benchmarks such as the BSE500, the stock’s returns and financial metrics lag significantly. This relative underperformance further supports the cautious stance reflected in the current rating.

Summary of Key Metrics as of 17 February 2026

To summarise, the stock’s Mojo Score stands at 31.0, corresponding to a 'Sell' grade. The quality grade is average, valuation is risky, financial trend is positive but fragile, and technical indicators remain bearish. Stock returns over various periods consistently show negative performance, with a notable 32.65% decline over the past year. These data points collectively underpin the current recommendation.

Conclusion

National Peroxide Ltd’s current 'Sell' rating by MarketsMOJO reflects a balanced assessment of its operational challenges, valuation risks, and market dynamics as of 17 February 2026. While there has been some improvement from a prior 'Strong Sell' rating, the company’s fundamentals and technical outlook suggest that investors should approach the stock with caution. Monitoring future developments and financial results will be essential for reassessing the stock’s potential in the coming months.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News